经皮硝酸甘油对绝经期潮热显示有限但潜在获益
Transdermal nitroglycerin shows limited but potential benefit for menopausal hot flashes
在The Menopause Society 2026年年会上报告的一项系统综述显示,经皮硝酸甘油对绝经后女性潮热的改善有限且结果不一致,或可成为存在激素治疗禁忌者的非激素选择。一项小型单臂研究中,最大剂量下每日潮热频率最多下降69%,停药后复发;头痛为最常见不良事件,治疗早期影响多达三分之二参与者。研究者认为现有证据有限、不精确且不一致,需更大规模试验明确疗效与安全性。
Hot flashes are the most frequent symptom of perimenopause and menopause, affecting 75% to 85% of women. In recent years, there has been a spike in the number of nonhormone options for managing hot flashes. A new study suggests that transdermal nitroglycerin may be an option. Results of the study were presented at the 2026 Annual Meeting of The Menopause Society in San Diego Oct. 20–24, 2026.
Menopausal hot flashes are not life-threatening, but frequent or severe episodes can significantly disrupt daily life. It is estimated that between 10% and 30% of women have symptoms that are severe enough to impair daily activities, work performance and overall quality of life. Night sweats can disrupt sleep, leading to chronic fatigue, irritability and mood changes.
Hormone therapy is widely considered the most effective (gold standard) medical treatment for moderate-to-severe hot flashes. However, not all women are willing or able to take hormones, which has led to an increase in the number of nonhormone treatments on the market today. Researchers in a new study sought to evaluate the impact of continuous transdermal nitroglycerin on hot flash frequency and related quality-of-life outcomes.
They reviewed four studies that included more than 160 participants in total. Results were inconsistent when comparing nitroglycerin to placebo and, in three of the four studies, any improvements observed were minimal.
However, in a small single-arm study, daily hot flash frequency decreased by up to 69% at the maximum nitroglycerin dose, with recurrence after discontinuation. Headaches were the most frequent adverse events, affecting up to two-thirds of participants early in treatment.
Based on the results, the researchers concluded that continuous transdermal nitroglycerin may provide modest reductions in hot flash frequency and represents a potential nonhormone option for postmenopausal women with contraindications to hormone therapy. They agreed, however, that evidence is limited, imprecise and inconsistent, and further well-powered trials are needed to clarify efficacy, safety and clinical utility of transdermal nitroglycerin in this population.
"Finding effective nonhormonal treatments for hot flashes is important because many women are unable or prefer not to use hormone therapy, yet these symptoms can significantly affect sleep, daily functioning and quality of life," says Dr. Flavia Fairbanks Ruano, lead author from the University of Miami Miller School of Medicine.
"Our findings suggest that transdermal nitroglycerin is an interesting potential nonhormonal approach, but the current evidence is still limited. Larger, well-designed trials are needed to determine whether this treatment can provide a meaningful benefit for patients."
Details of the study will be discussed as part of the presentation titled "Transdermal Nitroglycerin for Hot Flashes in Postmenopausal Women: A Systematic Review."
"Hot flashes can have a profound effect on sleep, daily functioning, work productivity and quality of life," says Dr. Stephanie Faubion, medical director for The Menopause Society.
"Although hormone therapy remains the most effective treatment for most women, there is an ongoing need for safe and effective nonhormone options. This review highlights transdermal nitroglycerin as a potentially promising approach, but the available evidence remains limited and inconsistent. Larger, well-designed studies are needed before its role in clinical practice can be determined."
More information
Transdermal Nitroglycerin for Hot Flashes in Postmenopausal Women: A Systematic Review.
Key medical concepts
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Transdermal nitroglycerin shows limited but potential benefit for menopausal hot flashes (2026, October 20) retrieved 20 October 2026 from https://medicalxpress.com/news/2026-10-transdermal-nitroglycerin-limited-potential-benefit.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com